Status:
NOT_YET_RECRUITING
A Cognitive Intervention to Manage 'Brain Fog' in Menopause Transition: Feasibility Study
Lead Sponsor:
University College, London
Conditions:
Menopause
Eligibility:
FEMALE
40-60 years
Phase:
NA
Brief Summary
Cognitive complaints at menopause transition (MT), often described as 'brain fog'; can include difficulty recalling words and numbers, misplacing items, trouble concentrating and forgetfulness. Whilst...
Eligibility Criteria
Inclusion
- people with ovaries (women, trans-men and non-binary people) aged 40-60
- late-reproductive, early-late perimenopause or early post-menopause stages according to the Stages of Reproductive Aging Workshop (STRAW+10; Harlow et al., 2012)
- stable dose of hormonal (oestrogen, progesterone, testosterone) or antidepressant (SSRI, SSNI) medication for 6 months or more
- self-reported cognitive difficulties impacting on quality of life
- ability to communicate in English
Exclusion
- diagnosis of dementia
- new regimen (under 6 months) of medication likely to impact on cognition (i.e. hormonal or anti-depressant)
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06940466
Start Date
June 1 2025
End Date
September 1 2026
Last Update
April 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University College London
London, United Kingdom, WC1E 6BT